期刊文献+

血管生成拟态在胃腺癌中的临床病理意义和相关机制研究 被引量:4

Mechanism of Vasculogenic Mimicry and Its Clinicopathologic Significance in Gastric Adenocarcinoma
暂未订购
导出
摘要 目的:探讨胃腺癌(gastric adenocarcinoma,GAC)中是否存在血管生成拟态(vasculogenic mimicry,VM),并进一步阐述VM存在的临床病理意义,通过金属基质蛋白酶-2、9(matrix metalloproteinase,MMP-2、MMP-9)和组织蛋白酶D(CathepsinD)的免疫组化染色,初步探讨VM的形成机制。方法:收集173例临床资料和随访资料完整的胃腺癌病例,通过过碘酸雪夫氏反应(Penodic acid—Schiff,PAS)与CD31双重染色和CK8&18免疫组化染色,将胃腺癌分成VM(+)组和VM(-)组,计数微血管密度(microvascular density,MVD)和血管拟态密度(vasculogenic mimicry density,VMD),并进行MMP-2、MMP-9和CathepsinD的免疫组化染色。结果:173例胃腺癌患者中VM阳性者40例(23.12%),低分化腺癌组VM阳性率(26.4%)明显高于中分化腺癌组(4%)(X^2=6.011,P=0.014);且VM(+)组更易发生血道转移和远期复发(X^2=6.389,P=-0.020;X^2=4.748,P=0.029);血道转移组VMD计数较无转移组明显升高(t=3.140,P=0.003)。MVD在VM(+)组和VM(-)组中的差异无统计学意义(F=1.596,P=0.482)。Kaplan—Meier生存分析显示VM(+)组的生存率低于VM(-)组(P=0.022),Cox回归模型显示TNM分期和VM是影响胃腺癌患者生存率的危险因素。VM(+)组MMP-2、MMP-9和Cathepsin D的表达均高于VM(-)组(P均〈0.05)。结论:胃腺癌中存在VM,且与分化程度有关,VM是胃腺癌不良预后的指标之一。MMP-2、MMP-9和Cathepsin D可能参与了GAC中VM的形成。 Objective: To explore whether vasculogenic mimicry (VM) exists in gastric adenocarcinoma (GAC) and to investigate the clinicopathologic significance of VM in GAC. Methods: We tended to illuminate the mechanism of VM by performing immunohistochemical staining of MMP-2, MMP-9 and Cathepsin D. A total of 173 GAC samples with detailed follow-up data were collected. CD31/periodic acid-Schiff (PAS) double staining and CK8 & 18 immunohistochemical staining were performed to validate the existence of VM in GAC. The values of MVD (microvascular density) and VMD (vasculogenic mimicry density) were counted respectively. Immunohistochemical staining of MMP-2, MMP-9 and Cathepsin D was performed for all samples. Results: VM was observed in 40 of the 173 GAC samples, especially in poorly differentiated GAC (P=0.014). Patients with VM were prone to hematogenous metastasis and distant recurrence compared with those without VM (P=-0.020, 0.029). Higher VMD count was also associated with hematogenous metastasis (P=0.003). There was not significant difference in MVD count between VM-positive and VM-negative groups (F=1.596, P=0.482). The Kaplan-Meier survival analysis showed that the survival duration of the VM-positive group was significantly shorter than that of VM-negative group (P=0.022). Cox proportional hazards model indicated that the VM and TNM stage were independent predictors for poor prognosis of GAC (P=0.039 and 0.004). The immunohistochemical expression of MMP-2, MMP-9 and Cathepsin D was higher in VM-positive group than in VM-negative group (P〈0.05). Conclusion: VM exists in GAC, especially in poorly differentiated GAC VM is an unfavorable prognostic indicator for GAC. MMP-2, MMP-9 and Cathepsin D might involve the formation of VM in GAC.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2010年第7期372-376,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30770828,30830049)
关键词 胃癌 腺癌 血管生成拟态 CD31/PAS双重染色 Gastric cancer Adenocarcinoma Vasculogenic mimicry CD31/PAS double-staining
  • 相关文献

参考文献10

  • 1Maniotis AJ,Folberg R,Hess A,et al.Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimic-ry[J].Am J Pathol,1999,155(3):739-752.
  • 2孙保存,张诗武,倪春生,刘志勇,戚红,张丹芳.377例双向分化恶性肿瘤血管生成拟态临床意义分析[J].中国肿瘤临床,2005,32(2):64-67. 被引量:6
  • 3郄硕,张诗武,张丹芳,郭华,张利华,孙保存.胃肠道间质瘤中血管生成拟态初步研究[J].中国肿瘤临床,2007,34(2):68-71. 被引量:17
  • 4Sun B,Zhang S,Zhang D,et al.Vasculogenic mimicry is associated with high tumor grade,invasion and metastasis,and short survival in patients with hepatocellular carcinoma[J].Oncol Rep,2006,16 (4):693-698.
  • 5Li G,Huang H,Donate F,et al.Prostate-specific membrane anti-gen directed selective thrombotic infarction of tumors[J].Cancer Res,2002,62(19):5470-5475.
  • 6Shirakawa K,Tsuda H,Heike Y,et al.Absence of endothelial cells,central necrosis,and fibrosis are associated with aggressive inflam-matory breast cancer[J].Cancer Res,2001,61(2):445-451.
  • 7Park SH,Han JX,Kim TK,et al.Unusual gastric tumors:radiolog-ic-pathologic correlation[J].Radiographics,1999,19(6):1435-1446.
  • 8Sood AK,Seftor EA,Fletcher MS,et al.Molecular determinants of ovarian cancer plasticity[J].Am J Pathol,2001,158(4):1279-1288.
  • 9张诗武,郭华,张丹芳,赵秀兰,谷彦军,孙保存.恶性黑色素瘤血管生成拟态的形态学观察[J].中国肿瘤临床,2005,32(23):1329-1332. 被引量:9
  • 10Zhang S,Zhang D,Sun B.Vasculogenic mimicry:current status and future prospects[J].Cancer Lett,2007,254(2):157-164.

二级参考文献29

  • 1Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and vitro: vasculogenic mimicry[J]. AmJ Pathol, 1999, 155 (3):739~752
  • 2Sood AK, Seffor EA, Fletcher MS, et al. Molecular determinants of ovarian cancer plasticity [J]. AmJ Pathol, 2001, 158 (4):1279~1287
  • 3Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption,regression and growth in tumors mediated by angiopoientins and VEGF[J]. Science, 1999, 284(3): 1994~1998
  • 4Seftor RE, Seftor EA, Koshikawa N, et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2,and membrane type-l-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma[J].Cancer Res, 2001, 61(17):6322~6327
  • 5Sharma N, Seftor RE, Seftor EA, et al. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry [J]. Prostate, 2002, 50(3) :189 ~201
  • 6Hendrix MJ, Seftor EA, Kirschmann DA, et al. Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells [J]. Breast Cancer Res,2000, 2(6):417~422
  • 7Sood AK, Flether MS, Zahn CM, et al. The clinical significance of tumor cell-lined vasculature in ovarian carcinoma [J]. Cancer Biol Ther, 2002, 1(6):661 ~664
  • 8Llyoyd RV, Vidal S, Horvath E, et al. Angiogenesis in normal and neoplastic pituitary tissues[J]. Microsc Res Tech, 2003, 60(2):244~250
  • 9Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and vitro :vasculogenic mimicry[J]. AMJ Pathol, 1999, 155(3): 739-752
  • 10Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis[J]. AmJ Pathol, 2000, 156(2): 361-381

共引文献29

同被引文献56

  • 1赵秀兰,杜静,张诗武,刘易欣,王欣,孙保存.肝细胞肝癌中血管生成拟态的研究[J].中华肝脏病杂志,2006,14(1):41-44. 被引量:42
  • 2苏敏,尧良清,丰有吉,金惠铭.肿瘤微循环的新形式——血管生成拟态[J].国际病理科学与临床杂志,2006,26(1):11-13. 被引量:4
  • 3刘宏胜.白藜芦醇抗肿瘤作用机制的研究进展[J].中草药,2007,38(2):312-314. 被引量:8
  • 4张宁宁,刘文超,薛妍.抗肿瘤血管生成治疗相关性研究[J].现代肿瘤医学,2007,15(7):1010-1012. 被引量:1
  • 5Geoghegan J G,Scheele J. Treatment of colorectal liver metastasis[J].British Journal of Surgery,1999,(02):158-169.
  • 6Romagnani P,Annunziato F,Lasagni L. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity[J].Journal of Clinical Investigation,2001,(01):53-63.
  • 7Foberg R,Maniotis A J. Vasculaogenic mimicry[J].AMPIS,2004,(7-8):508-525.
  • 8Zhang S,Zhang D,Sun B. Vasculaogenic mimicry current status and future prospects[J].Cancer Letters,2007,(02):157-164.
  • 9Tsuchiya T,Ohshima K,Karube K. Th1,Th2,and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma,unspecified:comparison with AILD,ALCL,lymphblastic lymphoma,and ATLL[J].Blood,2004,(01):236-241.
  • 10Terzi(c) J,Grivennikov S,Karin E. Inflammation and colon cancer[J].Gastroenterology,2010,(06):2101-2114.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部